Outcomes | Imaging findings | Adjusteda OR (95% CI) | P value |
---|---|---|---|
ICU admission | Ground glass | 0.42 (0.09–1.99) | 0.274 |
Consolidation | 2.23 (0.62–7.95) | 0.218 | |
Bilateral lung involvement | 3.66 (0.38–35.23) | 0.262 | |
Peribronchovascular distribution | 2.93 (1.92–4.47) | < 0.001 | |
Involved zones | 2.10 (1.55–2.86) | < 0.001 | |
CSS (continuous) | 1.14 (1.10–1.19) | < 0.001 | |
CSS ≥ 19 | 3.21 (2.15–4.81) | < 0.001 | |
Mortality | Consolidation | 1.72 (0.63–4.65) | 0.288 |
Peribronchovascular distribution | 2.30 (1.50–3.53) | < 0.001 | |
Involved zones | 1.35 (1.05–1.74) | 0.020 | |
CSS (continuous) | 1.08 (1.04–1.12) | < 0.001 | |
CSS ≥ 19 | 1.84 (1.21–2.81) | 0.004 | |
Disease severityb | |||
Severe | Ground glass | 0.51 (0.13–2.02) | 0.337 |
Consolidation | 4.94 (1.22–20.02) | 0.025 | |
Peribronchovascular distribution | 2.06 (1.26–3.35) | 0.004 | |
Involved zones | 1.68 (1.29–2.18) | 0.001 | |
CSS (continuous) | 1.10 (1.06–1.14) | < 0.001 | |
CSS ≥ 19 | 3.18 (2.05–4.93) | < 0.001 | |
Critical | Ground glass | 0.28 (0.04–1.89) | 0.195 |
Consolidation | 3.06 (0.74–12.68) | 0.123 | |
Peribronchovascular distribution | 4.62 (2.64–8.10) | < 0.001 | |
Involved zones | 3.21 (2.25–4.58) | < 0.001 | |
CSS (continuous) | 1.23 (1.16–1.29) | < 0.001 | |
CSS ≥ 19 | 6.25 (3.74–10.41) | < 0.001 |